首页|基于NF-κB通路探讨中医药治疗糖尿病心肌病研究进展

基于NF-κB通路探讨中医药治疗糖尿病心肌病研究进展

扫码查看
核转录因子-κB(nuclear factor kappa-B,NF-κB)是调控基因转录的重要因子,参与炎症反应及心肌纤维化等多种疾病的病理过程,中医药激活NF-κB通路且通过控制不同基因参与氧化应激、炎症、内皮功能障碍和细胞凋亡等过程而调控糖尿病心肌病.目前,靶向作用于NF-κB信号通路传导途径治疗糖尿病心肌病的中药单体、中成药、中药复方的相关研究存在以下问题:(1)相关研究多针对中药提取物,单味中药、复方及中药制剂的作用研究较少;(2)这些研究一般只针对NF-κB这一个通路,并未就通路间相互复杂联系进行交叉研究,明确各通路之间相互作用是阐明中药作用机制的重点;(3)大部分研究以体外细胞实验和动物实验为主,缺乏临床研究来进一步验证和支持.今后,应逐步拓宽研究对象范围,不仅包含中药单体,还应涉及单味中药、中药复方及中药制剂,也应涵盖多种剂型,突出中药区别于西药的特色;同时也要注重信号通路之间的关联,明确中药作用于疾病的完整作用机制;还应着重于从分子学、细胞学、生物学等多角度多学科对这一通路的调控作用进行更深入的实验和临床研究.
Research Progress of TCM in the Treatment of Diabetic Cardiomyopathy Based on NF-κB Pathway
Nuclear factor kappa-B(NF-κB)is an important factor in regulating gene transcription,and is involved in the pathological process of inflammation and myocardial fibrosis and other diseases.TCM regulates diabetic cardiomyopathy by activating NF-κB pathway and controlling different genes involved in oxidative stress,inflammation,endothelial dysfunction,fibrosis,myocardial hypertrophy and apoptosis.At present,there are the following problems in the research of Chinese medicinal monomers,patent Chinese medicine and compound Chinese medicinal formulas targeting NF-κB signaling pathway in the treatment of diabetic cardiomyopathy:(1)Most of the relevant research is focused on Chinese medicine extracts,and there are few studies on the effects of single Chinese medicinal,com-pound formula,Chinese medicinal preparations.(2)These studies generally only focus on NF-κB pathway,and there is no cross-study on the complex interaction between pathways.It is the key to clarify the interaction between pathways to clarify the mechanism of action of Chinese medicinals.(3)Most of the studies are mainly based on in vitro cell experiments and animal experiments,and there is a lack of clinical research to further verify and support.In the future,the research objects should be gradually expanded,not only including Chinese medicinal monomer,but also involving single Chinese medicinal,compound Chinese medicinal formulas and Chinese medicinal preparation,and it is necessary to cover a variety of dosage forms,highlighting the characteristics of TCM different from Western medi-cine;at the same time,we should pay attention to the correlation between signaling pathways,so as to clarify the complete mechanism of TCM action on the disease.We should also focus on the further experimental and clinical research on the regulation of this pathway from the perspectives of molecular,cytological,biological and other multidisciplinary.

diabetic cardiomyopathy(DCM)NF-κB signaling pathwayChinese medicinal monomerpatent Chinese medicinecom-pound Chinese medicinal formula

马金玲、冷锦红

展开 >

辽宁中医药大学,辽宁沈阳 110847

糖尿病心肌病 NF-κB信号通路 中药单体 中成药 中药复方

沈阳市科技计划项目

22-321-33-39

2024

河南中医
河南省中医药学会 河南中医学院

河南中医

影响因子:0.968
ISSN:1003-5028
年,卷(期):2024.44(2)
  • 78